Similar articles

• Natriuretic peptides in the diagnosis and management of acute heart failure.

  Mohammed AA, Januzzi JL Jr. Mohammed AA, et al. Heart Fail Clin. 2009 Oct;5(4):489-500. doi: 10.1016/j.hfc.2009.04.007. Heart Fail Clin. 2009. PMID: 19631174
• [Biomarkers in heart failure: are they clinically useful?].

  Kempf T, Wollert KC. Kempf T, et al. Dtsch Med Wochenschr. 2009 Apr;134(15):740-6. doi: 10.1055/s-0029-1220224. Epub 2009 Apr 1. Dtsch Med Wochenschr. 2009. PMID: 19340752 Review. German. No abstract available.
• Can we IMPROVE-CHF management by measuring natriuretic peptides?

  Greenberg B. Greenberg B. Circulation. 2007 Jun 19;115(24):3045-7. doi: 10.1161/CIRCULATIONAHA.107.714998. Circulation. 2007. PMID: 17576881 No abstract available.
• Sepsis and those who are "weak of heart".

  van Kimmenade RR, Bajwa E, Januzzi JL Jr. van Kimmenade RR, et al. Crit Care Med. 2008 Nov;36(11):3108-9. doi: 10.1097/CCM.0b013e31818bdc4a. Crit Care Med. 2008. PMID: 18941317 No abstract available.
• [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].

  Hradec J, Krupicka J, Janota T. Hradec J, et al. Cas Lek Cesk. 2009;148(8):383-8. Cas Lek Cesk. 2009. PMID: 19899725 Review. Czech.